Biotech Hedge Fund Bailed on Drugmaker Before Its Depression Treatment Scored (Bloomberg) Baker Bros. Advisors LP, a hedge fund known for making big biotechnology......
(read more)February 14 - Hedge Funds, Insider Trading - Comments
Baker Bros. Advisors purchased about 1.2 million shares of Acadia Pharmaceuticals Inc (NASDAQ:ACAD) for about $19 per share last week. Here is why the......
(read more)September 24 - Hedge Funds, Insider Trading, News - Comments
Genomic Health Inc (NASDAQ:GHDX): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros. Advisors......
(read more)March 15 - Hedge Funds - Comments
Idera Pharmaceuticals Inc. (NASDAQ:IDRA): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros......
(read more)March 12 - Hedge Funds - Comments
Seattle Genetics Inc (NASDAQ:SGEN): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros. Advisors......
(read more)February 7 - Hedge Funds - Comments
Beigene Ltd (ADR) (BGNE): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros. Advisors’......
(read more)January 26 - Hedge Funds - Comments
Mirati Therapeutics Inc. (NASDAQ:MRTX): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros.......
(read more)November 21 - Hedge Funds - Comments
Erytech Pharma SA (ADR) (NASDAQ:ERYP): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros. Advisors......
(read more)November 20 - Hedge Funds - Comments
Idera Pharmaceuticals Inc. (NASDAQ:IDRA): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros......
(read more)October 31 - Hedge Funds - Comments
Acadia Pharmaceuticals Inc (NASDAQ:ACAD): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros......
(read more)October 17 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing SECURITIES AND EXCHANGE COMMISSION......
(read more)August 15 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......
(read more)August 3 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 11 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......
(read more)June 2 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON......
(read more)May 18 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......
(read more)May 18 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing SCHEDULE 13G SECURITIES AND EXCHANGE......
(read more)April 15 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......
(read more)March 30 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 8 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......
(read more)March 30 - Hedge Funds - Comments
Some of the names we are going to show on this top 140 biggest and most famous activist hedge funds list are the investors that keep certain executives......
(read more)February 2 - Hedge Funds, News - Comments
Baker Bros. Advisors has arguably been the most successful healthcare-focused hedge fund on the Street in recent years. Founded by brothers Julian Baker......
(read more)November 24 - Hedge Fund Analysis, Hedge Funds, News - Comments
Baker Bros. Advisors is a fund managed by Julian Baker and Felix Baker that mainly invests in biotechnology companies, and today we are going to take......
(read more)November 14 - Hedge Funds, News - Comments
Julian Baker and Felix Baker founded Baker Bros. Advisors in 2000. The fund invests only in the healthcare sector, with a large chunk of its portfolio......
(read more)October 16 - Hedge Fund Analysis, Hedge Funds, News - Comments
A newly-amended 13D filing with the Securities and Exchange Commission revealed that Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) has signed an Underwriting......
(read more)September 22 - Hedge Funds, News - Comments
Julian and Felix Baker‘s Baker Bros. Advisors reported raising its stake in Seattle Genetics Inc (NASDAQ:SGEN) to 44.35 million common shares,......
(read more)September 16 - Hedge Funds, News - Comments
Julian Baker and Felix Baker‘s Baker Bros. Advisors recently filed an amended Form 13D with the SEC to report the sale of common shares of Biocryst......
(read more)August 17 - Hedge Funds, News - Comments
Julian Baker and Felix Baker, the managers of Baker Bros. Advisors, have taken advantage of Acadia Pharmaceuticals Inc (NASDAQ:ACAD) recently announced......
(read more)August 15 - Hedge Funds, News - Comments
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused......
(read more)May 7 - Hedge Fund Analysis, Hedge Funds, News - Comments
It is generally believed that individuals seeking to become millionaires (and who isn’t?) need to think and act like millionaires. That’s probably......
(read more)March 18 - Hedge Funds, News - Comments
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors. Among other things......
(read more)March 8 - Hedge Funds, News - Comments
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies......
(read more)February 25 - Hedge Funds, News - Comments
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors, by far the......
(read more)February 24 - Hedge Funds, News - Comments
Fresh statistics reveal that the 50 most popular stocks among hedge funds lost 10% in 2015, which practically means that individual investors should......
(read more)February 24 - Hedge Funds, News - Comments
As a new 13D filing with the SEC has revealed, Julian and Felix Bakers‘ Baker Bros. Advisors amassed a substantial position in the recently public......
(read more)February 22 - Hedge Funds, News - Comments
According to a recent filing with the Securities and Exchange Commission, Julian and Felix Bakers‘ Baker Bros. Advisors are bullish on Anacor Pharmaceuticals......
(read more)February 10 - Hedge Funds, News - Comments
According to statistics from Hedge Fund Research, the average hedge fund lost 2.76% in January, compared to a decline of approximately 5% for the S&......
(read more)February 10 - Hedge Funds, News - Comments
Most equity investments made by hedge funds are based on strong reasoning and comprehensive analysis, so these investment vehicles do not make blind......
(read more)January 29 - Hedge Funds, News - Comments
There are numerous exceptional money managers who have been able to consistently beat broader market benchmarks, which is just one reason why tracking......
(read more)January 28 - Hedge Funds, News - Comments
The hedge fund industry closed in negative territory for 2015, marking the fourth year of decline for the industry since 1990. Nonetheless, approximately......
(read more)January 22 - Commodities, Hedge Funds, News - Comments
At Insider Monkey, we closely monitor the moves made by activist investors. Their targets are often undervalued stocks with firm foundations that for......
(read more)January 20 - Hedge Funds - Comments
According to the Schulte, Roth & Zabel’s Activist Investing 2015 Annual Review, 344 companies were targeted by activist investors in 2014, as compared......
(read more)December 28 - Hedge Funds, News - Comments
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker......
(read more)December 9 - Hedge Fund Analysis, Hedge Funds, News - Comments
You don’t necessarily need millions of dollars to invest like an activist investor such as Carl Icahn or Bill Ackman. Extensive research has concluded......
(read more)November 23 - Hedge Fund Analysis, Hedge Funds, News - Comments
Most investors monitor hedge funds’ 13F filings in order to identify high-potential stocks, and our research has provided evidence that these public......
(read more)November 7 - Hedge Funds, News - Comments
Neal C. Bradsher‘s Broadwood Capital revealed in a recent Form 4 filing with the SEC that it has purchased an additional 2.43 million shares of......
(read more)September 17 - Hedge Funds, News - Comments
Julian Baker and Felix Baker’s Baker Bros. Advisors continues to relentlessly add shares to its position in Seattle Genetics, Inc. (NASDAQ:SGEN). In......
(read more)September 16 - Hedge Funds, News - Comments
At Insider Monkey, we track over 700 hedge funds and investment companies, which allows us to understand the market sentiment towards any given stock.......
(read more)August 17 - Hedge Fund Analysis, Hedge Funds, News - Comments
According to a freshly-amended 13G filing with the SEC, Baker Bros. Advisors LP, founded by Julian Baker and Felix Baker, revealed it owns 15.1% of DBV......
(read more)August 11 - Hedge Funds, News - Comments
Julian and Felix Baker’s Baker Bros. Advisors LP has filed a 13D filing in which it reported ownership of 4.27 million shares of Aquinox Pharmaceuticals......
(read more)August 10 - Hedge Funds, News - Comments
Was Baker Bros. Advisors‘ investment in XOMA Corp (NASDAQ:XOMA) a mistake? According to a recent filing with the Securities and Exchange Commission......
(read more)July 26 - Hedge Funds, News - Comments
Shares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC) soared to a lofty $140.00 per share pre-market high today, or a whopping 65.47% higher than the stock......
(read more)July 13 - Hedge Funds, News - Comments
